Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myeloma

BACKGROUND: Whole-body (WB) MRI, which includes diffusion-weighted imaging (DWI) and T(1)-w Dixon, permits sensitive detection of marrow disease in addition to qualitative and quantitative measurements of disease and response to treatment of bone marrow. We report on the first study to embed standar...

Descripción completa

Detalles Bibliográficos
Autores principales: Rata, Mihaela, Blackledge, Matthew, Scurr, Erica, Winfield, Jessica, Koh, Dow-Mu, Dragan, Alina, Candito, Antonio, King, Alexander, Rennie, Winston, Gaba, Suchi, Suresh, Priya, Malcolm, Paul, Davis, Amy, Nilak, Anjumara, Shah, Aarti, Gandhi, Sanjay, Albrizio, Mauro, Drury, Arnold, Roberts, Sadie, Jenner, Matthew, Brown, Sarah, Kaiser, Martin, Messiou, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334517/
https://www.ncbi.nlm.nih.gov/pubmed/35900614
http://dx.doi.org/10.1186/s13244-022-01253-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334517/
https://www.ncbi.nlm.nih.gov/pubmed/35900614
http://dx.doi.org/10.1186/s13244-022-01253-0

Ejemplares similares